ClinicalTrials.gov record
Recruiting Phase 2Phase 3 Interventional

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

ClinicalTrials.gov ID: NCT07106762

Public ClinicalTrials.gov record NCT07106762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

IZABRIGHT-Bladder01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy for Metastatic Urothelial Cancer in Participants With Disease Progression on or After an Immunotherapy-based Treatment

Study identification

NCT ID
NCT07106762
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
470 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Cisplatin Drug
  • Gemcitabine Drug
  • Iza-bren Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2025
Primary completion
Jan 25, 2029
Completion
Nov 17, 2033
Last update posted
Apr 14, 2026

2025 – 2033

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Local Institution - 0167 Gilbert Arizona 85234 Not yet recruiting
Local Institution - 0162 Fullerton California 92835 Not yet recruiting
Local Institution - 0252 Palo Alto California 94304 Not yet recruiting
Local Institution - 0163 Sacramento California 95816 Not yet recruiting
University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento California 95817 Recruiting
Local Institution - 0251 San Francisco California 94115 Not yet recruiting
Local Institution - 0254 Santa Rosa California 95403 Not yet recruiting
Local Institution - 0245 Dillon Colorado 80435 Withdrawn
Shaw Cancer Center Edwards Colorado 81632 Recruiting
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 Recruiting
Local Institution - 0247 Miami Florida 33176 Not yet recruiting
University of Kentucky Chandler Medical Center Lexington Kentucky 40536 Recruiting
Johns Hopkins Hospital Baltimore Maryland 21287 Recruiting
Local Institution - 0195 Boston Massachusetts 02215 Not yet recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Local Institution - 0248 Buffalo New York 14203 Not yet recruiting
Icahn School of Medicine at Mount Sinai New York New York 10029 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Fairview Hospital Cleveland Ohio 44111 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Local Institution - 0161 Columbus Ohio 43210 Not yet recruiting
Cleveland Clinic - Hillcrest Hospital Mayfield Heights Ohio 44124 Recruiting
Local Institution - 0141 Portland Oregon 97239 Not yet recruiting
Local Institution - 0186 Nashville Tennessee 37203 Not yet recruiting
Local Institution - 0084 Nashville Tennessee 37232 Not yet recruiting
Local Institution - 0249 Abilene Texas 79606 Not yet recruiting
Local Institution - 0187 Austin Texas 78705 Not yet recruiting
Intermountain Medical Center Murray Utah 84107 Recruiting
Local Institution - 0253 St. George Utah 84790 Not yet recruiting
University of Virginia Health System Charlottesville Virginia 22903 Recruiting
Local Institution - 0188 Norfolk Virginia 23502 Not yet recruiting
Local Institution - 0200 Seattle Washington 98101 Not yet recruiting
Local Institution - 0255 Seattle Washington 98109 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07106762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07106762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →